Results 1 to 10 of about 63 (45)
Acute renal failure in a patient with epidermolysis bullosa acquisita [PDF]
: Epidermolysis bullosa acquisita is a severe autoimmune subepidermal bullous disease. In this report, we described for the first time a patient with epidermolysis bullosa acquisita who developed acute renal failure.
Guowei Zhao, Qing Yang, Furen Zhang
doaj +1 more source
Methylprednisolone sodium succinate (MPSS) is a parenteral water-soluble corticosteroid ester. It gives three peaks methylprednisolone (MP), 17-methylprednisolone hemisuccinate (17-MPHS), and methylprednisolone hemisuccinate (MPHS) that share in the ...
Mostafa F. Al-Hakkani
doaj +1 more source
Abstract Corticoids have found their way into the globe of sports, due to their anti‐inflammatory properties, and have often found to be added to dietary supplements for illegally improving the effectiveness of their products. Earlier studies describe the detection of corticoids in several matrices, but this can be an incessant and continuous process ...
Abdul Khader Karakka Kal +6 more
wiley +1 more source
Background. The cell regeneration and blood supply of bone defect lesions are restricted under osteoporotic pathological conditions, which make the healing of bone defect of osteoporosis still a great challenge. The current therapeutic strategies that mainly inhibit bone resorption are not always satisfactory for osteoporotic bone defects, which make ...
Yifei Fang +4 more
wiley +1 more source
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases. [PDF]
The present study shows the advantages of liposome-based nano-drugs as a novel strategy of delivering active pharmaceutical ingredients for treatment of neurodegenerative diseases that involve neuroinflammation.
Keren Turjeman +9 more
doaj +1 more source
Introduction Data about the feasibility or stability of drugs prepared for intrathecal administration are scarce, especially concerning the possibility of mixing two or more compounds in the same syringe.
Gianluca Perego +5 more
openaire +2 more sources
Methylprednisolone is used in neonates to modulate cardiopulmonary bypass (CPB)–induced inflammation, but optimal dosing and exposure are unknown. We used plasma methylprednisolone and interleukin (IL)‐6 and IL‐10 concentrations from neonates enrolled in a randomized trial comparing one vs.
Christoph P. Hornik +6 more
wiley +1 more source
Methylprednisolone‐hemisuccinate and its metabolites in serum, urine and bile from two patients with acute graft rejection. [PDF]
Methylprednisolone‐hemisuccinate (MPHS), methylprednisolone (MP), 20‐ alpha‐hydroxy‐ (20 alpha HMP) and 20‐beta‐hydroxymethyl‐prednisolone (20 beta HMP) concentrations were measured in serum, urine and bile from two liver transplant recipients who had received 1 g MPHS by a 1 h intravenous infusion for treatment of an acute rejection episode.
G J, Lawson +3 more
openaire +2 more sources
Objective: To evaluate the clinical effect of retroaural injection of methylprednisolone sodium succinate combined with hyperbaric oxygen (HBO) on the treatment of noise-induced hearing loss.
Yan Yao, Lei Li
doaj +1 more source
Current treatments for severe lupus nephritis are limited by side effects due to poor drug targeting. This review explores how smart nanomaterials—like liposomes and biomimetic carriers—can precisely deliver drugs to overactive immune cells and the kidneys. These nanotherapeutics enhance efficacy, reduce toxicity, and enable combination strategies. The
Cheng Zhou +6 more
wiley +1 more source

